Clinical trial for Postpartum Depression (PPD)
Official title Methyl Donor-Rich Diet in the Postpartum Period
ClinicalTrials.gov ID: NCT07887178
What this study is testing
- What it's testing
- The study wants to find out whether a diet high in methyl‑donor nutrients improves postpartum depression, breastfeeding success, and infant weight.
- Who it's for
- New mothers who are breastfeeding and have low intake of certain nutrients like folate, choline, B‑vitamins, etc.
- What's involved
- Participants will keep a short food diary, then be randomly placed in either a diet program with nutrition counseling for two months or usual postpartum care. Their mood, breastfeeding, and baby’s weight will be checked.
- Time commitment
- The study lasts about two months with regular visits and diet assessments during that time.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Women aged 18-40 years.
- Women presenting within the first 15 days after delivery.
- Mothers who had a term delivery (≥37 completed weeks of gestation).
- Mothers who are breastfeeding and whose infants are exclusively breastfed.
- No diagnosed psychiatric disorder or related medication use.
You likely can't join if
- Development of serious postpartum complications, such as postpartum hemorrhage or sepsis.
- A maternal or infant health condition requiring prolonged hospitalization.
- Introduction of complementary foods to the infant during the study.
- Maternal smoking or alcohol use.
- Failure to adhere to the dietary intervention.
- Failure to attend follow-up assessments or voluntary withdrawal from the study.
See the full eligibility criteria
- Women aged 18-40 years.
- Women presenting within the first 15 days after delivery.
- Mothers who had a term delivery (≥37 completed weeks of gestation).
- Mothers who are breastfeeding and whose infants are exclusively breastfed.
- No diagnosed psychiatric disorder or related medication use.
- No use of dietary supplements, including omega-3 supplements.
- No special diet program.
- No history of gestational diabetes, type 1 or type 2 diabetes, or insulin resistance.
- No malabsorption-related disorders, such as celiac disease or Crohn's disease.
- At least one assessed methyl donor nutrient intake below two-thirds of the applicable recommended intake, based on a 3-day dietary record.
- Willingness to participate voluntarily.
- Development of serious postpartum complications, such as postpartum hemorrhage or sepsis.
- A maternal or infant health condition requiring prolonged hospitalization.
- Introduction of complementary foods to the infant during the study.
- Maternal smoking or alcohol use.
- Failure to adhere to the dietary intervention.
- Failure to attend follow-up assessments or voluntary withdrawal from the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Bursa, Orhaneli̇, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Bursa, Orhaneli̇, Turkey (Türkiye). Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.